| Dr Brent M Adcox, MD | |
|
4201 Bartlett St Ste 201, Homer, AK 99603-7015 | |
| (907) 235-0310 | |
| (907) 235-0276 |
| Full Name | Dr Brent M Adcox |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 4201 Bartlett St Ste 201, Homer, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437339454 | NPI | - | NPPES |
| 2023301-01 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Peninsula Hospital | Homer, AK | Hospital |
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Peninsula Hospital Inc | 5395636930 | 43 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that data regarding Marqibo for treatment of adults with relapsed/refractory acute lymphoblastic leukemia (ALL) will be the subject of two presentations at the 2010 Annual Meeting and Exposition of the American Society of Hematology (ASH) being held in Orlando, Florida from December 4-7, 2010.
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
I have been working on this topic for 13 years. Our research programme centres around generating research evidence which can be used in public policy to promote health. This is a broad topic and investigates the potential for investment in socio-economic determinants of health, like housing, transport, welfare, employment etc, to have an impact on health.
› Verified 5 days ago
| Entity Name | South Peninsula Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that data regarding Marqibo for treatment of adults with relapsed/refractory acute lymphoblastic leukemia (ALL) will be the subject of two presentations at the 2010 Annual Meeting and Exposition of the American Society of Hematology (ASH) being held in Orlando, Florida from December 4-7, 2010.
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
I have been working on this topic for 13 years. Our research programme centres around generating research evidence which can be used in public policy to promote health. This is a broad topic and investigates the potential for investment in socio-economic determinants of health, like housing, transport, welfare, employment etc, to have an impact on health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brent M Adcox, MD 4201 Bartlett St Ste 201, Homer, AK 99603-7015 Ph: (907) 235-0310 | Dr Brent M Adcox, MD 4201 Bartlett St Ste 201, Homer, AK 99603-7015 Ph: (907) 235-0310 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that data regarding Marqibo for treatment of adults with relapsed/refractory acute lymphoblastic leukemia (ALL) will be the subject of two presentations at the 2010 Annual Meeting and Exposition of the American Society of Hematology (ASH) being held in Orlando, Florida from December 4-7, 2010.
Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.
Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.
I have been working on this topic for 13 years. Our research programme centres around generating research evidence which can be used in public policy to promote health. This is a broad topic and investigates the potential for investment in socio-economic determinants of health, like housing, transport, welfare, employment etc, to have an impact on health.
› Verified 5 days ago